Skip to content
value.today

Derm Holdings LLC

🇺🇸 Boca Raton, Florida, USAHospitals and Physicians
Total raised
$93 M
2 rounds on record
Latest round
$90 M
Feb 2023
First round on record
Aug 2012
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Derm Holdings LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$90 MNo. 2$50 to $250 million

Derm Holdings LLC: Raise no. 2, Feb 2023

Investors in this round

3 investors had bought by the notice of Feb 28, 2023: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$90 M of $90 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,997,330
Finders' fees
none
Paid to its own people
$19,462,500 (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Glen Stein · Executive Officer, Director
  • Jeffrey Queen · Executive Officer, Director
  • Andrew Queen · Director
  • Christopher Boehm · Director
  • Eric Becker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Deutsche Bank Securities Inc. (CRD 2525) · New York, New YorkSold in FL, NY

Signed by Jeffrey Queen, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 28, 2023. Read the notice at the SEC.

equitySEC
Aug 2012$3 MNo. 1$2 to $10 million

Derm Holdings LLC: Raise no. 1, Aug 2012

Investors in this round

38 investors had bought by the notice of Sep 7, 2012: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $5 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
$805,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Andrew Queen · Executive Officer, Director · Manager and Chairman of the Board
  • Gerard Christopher · Executive Officer, Director · Manager and Chief Operating Officer
  • Jeffrey Queen · Executive Officer · Manager and President
  • Adam Plotkin, MD · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · Seattle, WashingtonSold in CA, CO, CT, FL, HI, MA, MI, MN, NJ, NY, PA, TX, WA

Remarks in the notice

  • On fees: “The estimate is based on an offering of $8,050,000 with the placement agent receiving $805,000 in cash & warrants to buy 402,500 units at $1 per Preferred Unit. The placement agent has received $261,000 in cash & warrants to buy 130,500 Preferred Units.”
  • On the amounts: “We intend to sell between 25 units and 70 units plus at our placement agent's option up to an additional aggregate amount of 10.5 units for an aggregate offering price of between $2,500,000 and $7,000,000 or an aggregate total of $8,050,000.”
  • On the use of proceeds: “We expect to use net proceeds for the acquisition of dermatology practices including about $1,675,000 in connection with signed acquisition contracts, general working capital purposes and between $225,000 & $500,000 to pay eDerm Systems, LLC for a license”

Signed by Gerard Christopher, Manager & COO. Source: SEC Form D, newest notice filed Sep 7, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Derm Holdings LLC chose not to state its revenue in its newest notice of a funding round (Feb 2023).

    SEC Form D · Feb 2023

  • The industry group it chose in its notices: Hospitals and Physicians.

    SEC Form D · Feb 2023

That is all the official record says: Derm Holdings LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Derm Holdings LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 38 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Derm Holdings LLC
NameRoleNamed in
Glen SteinExecutive officerFeb 2023
Jeffrey QueenExecutive officerFeb 2023
Andrew QueenManager and Chairman of the BoardSep 2012
Gerard ChristopherManager and Chief Operating OfficerSep 2012
Andrew QueenDirectorFeb 2023
Christopher BoehmDirectorFeb 2023
Eric BeckerDirectorFeb 2023
Glen SteinDirectorFeb 2023
Jeffrey QueenDirectorFeb 2023
Adam Plotkin, MDManagerSep 2012
Gerard ChristopherManager and Chief Operating OfficerSep 2012